FACTBOX-J&J’s legal liabilities as it plans to split

- Advertisement -

Nov 12 (Businesshala) – Johnson & Johnson said on Friday it would split into two companies here, separating its consumer health division that sells Band-aids and baby powder from its pharmaceuticals and medical devices business.

- Advertisement -

Different companies must split different legal liabilities. Here are the biggest:

johnson’s baby powder

- Advertisement -

Its baby powder and other talc products were accused in nearly 40,000 lawsuits of containing asbestos and cancer, which the company denies. The plaintiffs include women with ovarian cancer and others battling mesothelioma. J&J has offered to contribute $2 billion to resolve remaining talc litigation as part of the bankruptcy reorganization of the newly created subsidiary. Here


J&J and three of America’s largest drug distributors — McKesson Corp, AmerisourceBergen Corp and Cardinal Health Inc — agreed in July to pay up to $26 billion to settle lawsuits by state and local governments that claimed That he fueled the opioid epidemic. J&J, which was named in 3,300 lawsuits, will pay up to $5 billion. The agreement has not been finalized and eight states are not participating. The Oklahoma Supreme Court on Tuesday overturned a $465 million judgment against J&K in a lawsuit by the state alleging it deceptively marketed painkillers to reduce their addictive risk. become.


- Advertisement -

Johnson & Johnson and Costco Wholesale Corp. said in a court filing on October 29 that they had reached a tentative agreement to settle lawsuits over the presence of a cancer-causing substance in several recalled J&J sunscreen products. J&J voluntarily withdrew four Neutrogena Aerosol sunscreen products and one Aveeno on July 14, after small amounts of benzene, a carcinogen, were found. Consumers sued Neutrogena and Aveeno-branded aerosol sunscreen products.


J&J revealed on October 29 that it had settled most of the lawsuits faced by thousands of men here who claimed that its anti-psychotic drug Risperdal caused them to develop excessive breast tissue, and that the settlement $800 million in expenses were recorded in relation to. More than nine thousand cases are pending. The deal covered a case that resulted in an $8 billion punitive damages award in 2019, which was later reduced to $6.8 million by a Philadelphia judge.

hip implants

In 2013 J&J’s DePuy orthopedics unit announced it would pay up to $2.5 billion here to settle cases of people accused of injuries caused by the metal-on-metal ASR hip-replacement system. It reached further agreements in 2015 and 2017 to settle additional claims by patients, allowing it to settle a total of more than 10,000 cases. J&J says it has settled related class actions in Australia and Canada.

The company has also faced lawsuits over its pinnacle metal-on-metal hip implants. After several adverse jury decisions, it agreed to settle thousands of cases in 2019. Lawsuits are being filed and J&K says 5,400 are pending.

pelvic plexus

J&J and other manufacturers of pelvic mesh products have faced thousands of lawsuits by women, claiming they suffered traumatic injuries and difficulty removing the devices. More than 104,000 cases against seven manufacturers, including J&J, were consolidated before a federal judge in West Virginia and resulted in more than $7.25 billion in settlements as of 2019. J&J, in its October 30 quarterly report, said it had resolved most of the cases but still faced 10,700 claims. (Editing by Edward Tobin)


- Advertisement -

Stay on top - Get the daily news in your inbox

DMCA / Correction Notice

Recent Articles

Related Stories

Stay on top - Get the daily news in your inbox